ACELLULAR TISSUE ENGINEERED VESSEL

FDA Drug Profile — Symvess

Drug Details

Generic Name
ACELLULAR TISSUE ENGINEERED VESSEL
Brand Names
Symvess
Application Number
BLA125812
Sponsor
Humacyte Global, Inc.
NDC Codes
1
Dosage Forms
IMPLANT
Routes
INTRAVASCULAR
Active Ingredients
ACELLULAR TISSUE ENGINEERED VESSEL

Indications and Usage

1 INDICATIONS AND USAGE SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. ( 1 )